Literature DB >> 16449285

Therapeutic approach in patients with dysnatraemias.

George Liamis1, Michalis Kalogirou, Vasilios Saugos, Moses Elisaf.   

Abstract

BACKGROUND: Rapid correction of dysnatraemias is frequently associated with increased morbidity and mortality. Therefore, it is important to estimate the proper volume and type of infusate required to change the serum sodium concentration predictably. The aim of this study is to evaluate the utility or/and the accuracy of the Adrogue-Madias formula in managing patients with hyponatraemia and hypernatraemia.
METHODS: Among the 317 patients who either on admission to our internal medicine clinic or during their hospitalization were found to have hyponatraemia or hypernatraemia, we studied 189 patients (59.6%) in whom the administration of intravenous solutions was required for the correction of dysnatraemias.
RESULTS: Twelve hours after starting the administration of intravenous solutions the anticipated as well as the achieved serum sodium concentration were as follows: in volume depleted patients 130.2+/-4.1 vs 131.3+/-5.2 meq/l (n = 45; P = NS), in syndrome of inappropriate antidiuretic hormone secretion (SIADH) patients 127.4+/-5.7 vs 128.9+/-5.9 meq/l (n = 10; P = NS), in patients with diuretic-induced hyponatraemia 123.8+/-6 vs 125.5+/-5.6 meq/l (n = 29; P = NS), in patients with primary polydipsia 122.5+/-0.7 vs 129+/-1.4 meq/l (n = 2; P = 0.02), while in patients with hypernatraemia 153.6+/-7.5 vs 156.5+/-8.9 meq/l (n = 92; P = 0.021). Furthermore, 24 h from the initiation of the therapeutic intervention the expected and the achieved serum sodium concentrations were 130+/-4 vs 135.6+/-3.3 meq/l (n = 15; P = 0.002) in patients with volume depletion, 128.1+/-4.8 vs 130+/-4.5 meq/l (n = 15; P = NS) in patients with diuretic-induced hyponatraemia and 151.5+/-6.4 vs 153.3+/-8.3 meq/l (n = 67; P = NS) in patients with hypernatraemia.
CONCLUSIONS: The formula that has been proposed by Adrogue and Madias predicted with relative accuracy the changes in serum sodium concentration in almost all patients. Thus, it should be considered as a very useful tool for the management of dysnatraemias. However, special attention should be paid when this equation is used in patients with hyponatraemia due to extracellular volume depletion after euvolaemia's restoration and primary polydipsia in order to avoid rapid correction of hyponatraemia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16449285     DOI: 10.1093/ndt/gfk090

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  25 in total

1.  Effect of hypoxia on the cerebral adaptation to acute hyponatremia in experimental animals.

Authors:  Howard Trachtman
Journal:  Pediatr Nephrol       Date:  2006-10-17       Impact factor: 3.714

Review 2.  Hyponatraemia in clinical practice.

Authors:  M Biswas; J S Davies
Journal:  Postgrad Med J       Date:  2007-06       Impact factor: 2.401

3.  The association between sodium fluctuations and mortality in surgical patients requiring intensive care.

Authors:  Dominic C Marshall; Justin D Salciccioli; Ross J Goodson; Marco A Pimentel; Kristi Y Sun; Leo Anthony Celi; Joseph Shalhoub
Journal:  J Crit Care       Date:  2017-02-13       Impact factor: 3.425

Review 4.  Diagnosis and Treatment of Hyponatremia: Compilation of the Guidelines.

Authors:  Ewout J Hoorn; Robert Zietse
Journal:  J Am Soc Nephrol       Date:  2017-02-07       Impact factor: 10.121

Review 5.  Diabetes mellitus and electrolyte disorders.

Authors:  George Liamis; Evangelos Liberopoulos; Fotios Barkas; Moses Elisaf
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

Review 6.  Improving on the Adrogué-Madias Formula.

Authors:  Sheldon Chen; Michael Shieh; Robert Chiaramonte; Jason Shey
Journal:  Kidney360       Date:  2020-12-04

7.  Current and future treatment options in SIADH.

Authors:  Robert Zietse; Nils van der Lubbe; Ewout J Hoorn
Journal:  NDT Plus       Date:  2009-11

8.  Efficacy of 3% saline vs. conivaptan in achieving hyponatremia treatment goals.

Authors:  Manuel Dominguez; Jose A Perez; Chirag B Patel
Journal:  Methodist Debakey Cardiovasc J       Date:  2013 Jan-Mar

Review 9.  Diagnosis and management of hyponatremia in acute illness.

Authors:  Robert W Schrier; Shweta Bansal
Journal:  Curr Opin Crit Care       Date:  2008-12       Impact factor: 3.687

10.  SIADH and hyponatraemia: why does it matter?

Authors:  Ewout J Hoorn; Nils van der Lubbe; Robert Zietse
Journal:  NDT Plus       Date:  2009-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.